Fate Therapeutics Inc (NASDAQ:FATE) shares, rose in value on Thursday, July 10, with the stock price up by 0.87% to the previous day’s close as strong demand from buyers drove the stock to $1.16. Actively observing the price movement in the last trading, the stock
The trading price of Fate Therapeutics Inc (NASDAQ:FATE) closed lower on Monday, July 07, and closing at $1.06, -5.36% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $1.05 and $1.13. In examining the
Fate Therapeutics Inc (NASDAQ:FATE) price closed higher on Monday, June 30, and jumping 7.69% above its previous close. A look at the daily price movement shows that the last close reads $1.04, with intraday deals fluctuated between $1.05 and $1.1999. The company’s 5Y monthly beta
Fate Therapeutics Inc (NASDAQ:FATE) concluded the trading at $1.1 on Thursday, June 26 with a fall of -5.17% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.16 and 5Y monthly beta
Fate Therapeutics Inc (NASDAQ:FATE) traded at $1.21 at close of the session on Friday, June 20 and made an upward move of 1.19% on its previous day’s price. Looking at the stock we see that its previous close was $5.40 and the beta (5Y monthly)
The trading price of Fate Therapeutics Inc (NASDAQ:FATE) closed lower on Friday, June 13, and closing at $1.27, -8.93% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $1.27 and $1.4. In examining the
Fate Therapeutics Inc (NASDAQ:FATE) price closed higher on current market day and jumping 9.87% above its previous close. A look at the daily price movement shows that the last close reads $1.52. Taking into account the 52-week price action we note that the stock hit
Fate Therapeutics Inc (NASDAQ:FATE) traded at $1.30 at close of the session on Monday, June 02 and made an upward move of 7.44% on its previous day’s price. Fate Therapeutics Inc has a market cap of $149.02 million and is expected to release its quarterly
Fate Therapeutics Inc (NASDAQ:FATE) shares, rose in value, with the stock price up by 4.10% to the previous day’s close as strong demand from buyers drove the stock to $1.27. Actively observing the price movement in the last trading, the stock closed the session at
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.